Table 2 Significant markers of post-transplant survival.

From: Alterations in the kallikrein-kinin system predict death after heart transplant

 

AUROC 2.5%

AUROC

AUROC 97.5%

Beta 2.5%

Beta

Beta 97.5%

F9

0.634

0.658

0.685

1.261

2.188

3.443

F2

0.649

0.670

0.684

1.240

2.036

2.758

SERPINF2

0.621

0.642

0.663

0.975

1.909

2.662

CPB2

0.590

0.608

0.631

0.800

1.651

2.782

ITIH2

0.574

0.590

0.611

0.663

1.334

1.998

FBLN1

0.569

0.595

0.618

0.443

1.288

2.432

CLEC3B

0.536

0.556

0.579

0.413

1.240

2.057

HPR

0.559

0.583

0.604

0.444

1.207

2.297

HGFAC

0.584

0.603

0.628

0.335

1.162

2.168

CD5L

0.543

0.564

0.583

0.265

1.138

2.018

KRT10

0.579

0.599

0.618

0.075

0.963

1.994

FCN2

0.518

0.539

0.563

0.053

0.894

1.753

Inotrope Therapy

0.536

0.558

0.578

0.428

0.794

1.248

PF4

0.505

0.525

0.543

0.114

0.762

1.769

Diabetes

0.508

0.527

0.555

− 0.956

− 0.566

− 0.099

Blood type A

0.526

0.544

0.570

− 1.016

− 0.712

− 0.298

LK

0.585

0.604

0.628

− 2.272

− 1.421

− 0.445

PGD

0.706

0.723

0.744

− 2.513

− 2.055

− 1.726

  1. Bold values significantly predicted post-transplant survival after adjustment for patient site-of-origin. The positive control, PGD, is highlighted in italics.
  2. PGD primary graft dysfunction, LMW low molecular weight.
Back to article page